| Product Code: ETC5634972 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Sepsis Diagnostics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Sepsis Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Sepsis Diagnostics Market - Industry Life Cycle |
3.4 Ireland Sepsis Diagnostics Market - Porter's Five Forces |
3.5 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.9 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Ireland Sepsis Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Sepsis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of sepsis cases in Ireland |
4.2.2 Growing awareness about early diagnosis and treatment of sepsis |
4.2.3 Technological advancements in sepsis diagnostic tools |
4.2.4 Supportive government initiatives for improving healthcare infrastructure |
4.2.5 Rising demand for point-of-care testing for sepsis |
4.3 Market Restraints |
4.3.1 High cost associated with sepsis diagnostic tests |
4.3.2 Limited access to advanced sepsis diagnostic technologies in remote areas |
4.3.3 Lack of skilled healthcare professionals for accurate diagnosis |
4.3.4 Regulatory challenges related to the approval process for new diagnostic tools |
4.3.5 Competition from alternative diagnostic methods for sepsis |
5 Ireland Sepsis Diagnostics Market Trends |
6 Ireland Sepsis Diagnostics Market Segmentations |
6.1 Ireland Sepsis Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Blood Culture, 2021-2031F |
6.1.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Immunoassays, 2021-2031F |
6.1.4 Ireland Sepsis Diagnostics Market Revenues & Volume, By Molecular Diagnostics, 2021-2031F |
6.1.5 Ireland Sepsis Diagnostics Market Revenues & Volume, By Flow Cytometry, 2021-2031F |
6.1.6 Ireland Sepsis Diagnostics Market Revenues & Volume, By Microfluidics, 2021-2031F |
6.1.7 Ireland Sepsis Diagnostics Market Revenues & Volume, By Biomarkers, 2021-2031F |
6.2 Ireland Sepsis Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Blood Culture Media, 2021-2031F |
6.2.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Assays & Reagents, 2021-2031F |
6.2.4 Ireland Sepsis Diagnostics Market Revenues & Volume, By Instruments, 2021-2031F |
6.2.5 Ireland Sepsis Diagnostics Market Revenues & Volume, By Software, 2021-2031F |
6.3 Ireland Sepsis Diagnostics Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Automated Diagnostics, 2021-2031F |
6.3.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Conventional Diagnostics, 2021-2031F |
6.4 Ireland Sepsis Diagnostics Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Bacterial Sepsis, 2021-2031F |
6.4.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Fungal Sepsis, 2021-2031F |
6.4.4 Ireland Sepsis Diagnostics Market Revenues & Volume, By Viral Sepsis, 2021-2031F |
6.4.5 Ireland Sepsis Diagnostics Market Revenues & Volume, By Other Pathogen, 2021-2031F |
6.5 Ireland Sepsis Diagnostics Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Laboratory Tests, 2021-2031F |
6.5.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Point-of-Care Tests, 2021-2031F |
6.6 Ireland Sepsis Diagnostics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Ireland Sepsis Diagnostics Market Revenues & Volume, By Hospitals and specialty clinics, 2021-2031F |
6.6.3 Ireland Sepsis Diagnostics Market Revenues & Volume, By Pathology & Reference Laboratories, 2021-2031F |
6.6.4 Ireland Sepsis Diagnostics Market Revenues & Volume, By Research Laboratories & Academic Institutes, 2021-2031F |
7 Ireland Sepsis Diagnostics Market Import-Export Trade Statistics |
7.1 Ireland Sepsis Diagnostics Market Export to Major Countries |
7.2 Ireland Sepsis Diagnostics Market Imports from Major Countries |
8 Ireland Sepsis Diagnostics Market Key Performance Indicators |
8.1 Average time taken for sepsis diagnosis in healthcare facilities |
8.2 Number of sepsis cases diagnosed at early stages |
8.3 Adoption rate of new sepsis diagnostic technologies |
8.4 Rate of sepsis-related mortality in Ireland |
8.5 Percentage of healthcare facilities equipped with sepsis diagnostic tools |
9 Ireland Sepsis Diagnostics Market - Opportunity Assessment |
9.1 Ireland Sepsis Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Sepsis Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Ireland Sepsis Diagnostics Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 Ireland Sepsis Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.5 Ireland Sepsis Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Ireland Sepsis Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Sepsis Diagnostics Market - Competitive Landscape |
10.1 Ireland Sepsis Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Sepsis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here